Pearl River Capital’s NeoGenomics NEO Stock Holding History

Pearl River Capital’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-47	Closed	-$1K	–	490
2020 Q1	$1K	Buy	+47	New	+$1.41K	﹤0.01%	470
2019 Q1	–	Sell	-590	Closed	-$7K	–	632
2018 Q4	$7K	Buy	+590	New	+$8.79K	0.03%	648

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pearl River Capital's NEO Position: Q2 2020 in Review

Pearl River Capital sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 47 shares — an estimated $1K sold.

Pearl River Capital first reported a position in NEO in Q4 2018 and held it in 2 quarters. The position peaked at $7K in Q4 2018. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

Pearl River Capital reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
Pearl River Capital sold 47 NeoGenomics shares in Q2 2020, an estimated $1K.
Pearl River Capital first reported a position in NeoGenomics in Q4 2018 and held it in 2 quarters.
Pearl River Capital's NeoGenomics position peaked at $7K in Q4 2018.
285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on Pearl River Capital's 13F filing for Q2 2020, filed 10 Aug 2020.